Comparison of New Drug Accessibility and Price Between Japan and Major European Countries

2017 ◽  
Vol 51 (5) ◽  
pp. 604-611 ◽  
Author(s):  
Akane Takayama ◽  
Mamoru Narukawa
2018 ◽  
Vol 1 (1) ◽  
Author(s):  
Mike Eaton

European countries have invested heavily in Nanomedicine over the last decade, however, the output has been much reduced by a lack of knowledge of how to innovate in a heavily regulated setting. This development failing is not unique to nanomedicine but is there to differing extents across most open innovation healthcare projects. The transition from research to development requires informed debate and high-quality data and is a very challenging milestone. Researchers often say they are developing a new drug, when they are in fact doing research – funders also use the terms (R or D) interchangeably - an unfortunate consequence of their academic training. A simple test is if you don’t know actually what you are developing - you are in research.


2019 ◽  
Vol 3 (6) ◽  
pp. 723-729
Author(s):  
Roslyn Gleadow ◽  
Jim Hanan ◽  
Alan Dorin

Food security and the sustainability of native ecosystems depends on plant-insect interactions in countless ways. Recently reported rapid and immense declines in insect numbers due to climate change, the use of pesticides and herbicides, the introduction of agricultural monocultures, and the destruction of insect native habitat, are all potential contributors to this grave situation. Some researchers are working towards a future where natural insect pollinators might be replaced with free-flying robotic bees, an ecologically problematic proposal. We argue instead that creating environments that are friendly to bees and exploring the use of other species for pollination and bio-control, particularly in non-European countries, are more ecologically sound approaches. The computer simulation of insect-plant interactions is a far more measured application of technology that may assist in managing, or averting, ‘Insect Armageddon' from both practical and ethical viewpoints.


ASHA Leader ◽  
2013 ◽  
Vol 18 (3) ◽  
pp. 33-33

Discovery of Alzheimer's Molecular Pathway Reveals New Drug Targets


2005 ◽  
Vol 39 (3) ◽  
pp. 51
Author(s):  
JENNIFER SILVERMAN
Keyword(s):  

2012 ◽  
Vol 43 (2) ◽  
pp. 10
Author(s):  
ALICIA AULT
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document